These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pharmaceutical analysis combined with in-silico therapeutic and toxicological profiling on zileuton and its impurities to assist in modern drug discovery. Ganorkar SB; Vander Heyden Y; Shirkhedkar AA; Lokwani DK; Dhumal DM; Bobade PS J Pharm Biomed Anal; 2020 Feb; 179():112982. PubMed ID: 31785932 [TBL] [Abstract][Full Text] [Related]
6. Application of Haider M; Chauhan A; Tariq S; Pathak DP; Siddiqui N; Ali S; Pottoo FH; Ali R Curr Top Med Chem; 2021; 21(11):995-1011. PubMed ID: 34061002 [TBL] [Abstract][Full Text] [Related]
7. In silico predictions of ADME-Tox properties: drug absorption. Geerts T; Vander Heyden Y Comb Chem High Throughput Screen; 2011 Jun; 14(5):339-61. PubMed ID: 21470183 [TBL] [Abstract][Full Text] [Related]
8. High-throughput and in silico techniques in drug metabolism and pharmacokinetics. van de Waterbeemd H Curr Opin Drug Discov Devel; 2002 Jan; 5(1):33-43. PubMed ID: 11865671 [TBL] [Abstract][Full Text] [Related]
9. In silico toxicology for the pharmaceutical sciences. Valerio LG Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836 [TBL] [Abstract][Full Text] [Related]
10. In silico exploration of c-KIT inhibitors by pharmaco-informatics methodology: pharmacophore modeling, 3D QSAR, docking studies, and virtual screening. Chaudhari P; Bari S Mol Divers; 2016 Feb; 20(1):41-53. PubMed ID: 26416560 [TBL] [Abstract][Full Text] [Related]
11. Relative Binding Free Energy Calculations in Drug Discovery: Recent Advances and Practical Considerations. Cournia Z; Allen B; Sherman W J Chem Inf Model; 2017 Dec; 57(12):2911-2937. PubMed ID: 29243483 [TBL] [Abstract][Full Text] [Related]
12. Toward in silico structure-based ADMET prediction in drug discovery. Moroy G; Martiny VY; Vayer P; Villoutreix BO; Miteva MA Drug Discov Today; 2012 Jan; 17(1-2):44-55. PubMed ID: 22056716 [TBL] [Abstract][Full Text] [Related]
13. Impact of Pharmaceuticals on the Environment: Risk Assessment Using QSAR Modeling Approach. Kar S; Roy K; Leszczynski J Methods Mol Biol; 2018; 1800():395-443. PubMed ID: 29934904 [TBL] [Abstract][Full Text] [Related]
14. Molecular Modeling Strategies of Cancer Multidrug Resistance. Yalcin-Ozkat G Drug Resist Updat; 2021 Dec; 59():100789. PubMed ID: 34973929 [TBL] [Abstract][Full Text] [Related]
15. In silico approaches for predicting ADME properties of drugs. Yamashita F; Hashida M Drug Metab Pharmacokinet; 2004 Oct; 19(5):327-38. PubMed ID: 15548844 [TBL] [Abstract][Full Text] [Related]
16. Modern drug discovery technologies: opportunities and challenges in lead discovery. Guido RV; Oliva G; Andricopulo AD Comb Chem High Throughput Screen; 2011 Dec; 14(10):830-9. PubMed ID: 21843147 [TBL] [Abstract][Full Text] [Related]
17. The current limits in virtual screening and property prediction. Hutter MC Future Med Chem; 2018 Jul; 10(13):1623-1635. PubMed ID: 29953247 [TBL] [Abstract][Full Text] [Related]
18. Predictive DMPK: in silico ADME predictions in drug discovery. Kenny JR Mol Pharm; 2013 Apr; 10(4):1151-2. PubMed ID: 23540938 [No Abstract] [Full Text] [Related]
19. Molecular Docking: Shifting Paradigms in Drug Discovery. Pinzi L; Rastelli G Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31487867 [TBL] [Abstract][Full Text] [Related]
20. A Combined Approach of Pharmacophore Modeling, QSAR Study, Molecular Docking and In silico ADME/Tox Prediction of 4-Arylthio & 4-Aryloxy-3- Iodopyridine-2(1H)-one Analogs to Identify Potential Reverse Transcriptase Inhibitor: Anti-HIV Agents. Panigrahi D; Mishra A; Sahu SK; Azam MA; Vyshaag CM Med Chem; 2022; 18(1):51-87. PubMed ID: 33319692 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]